Clinical Trial Update: Efficacy, Safety and Tolerability of Neramexane in Comparison to Placebo in Patients With Subjective Tinnitus [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing neramexane to placebo in patients with subjective tinnitus evaluated efficacy, safety and tolerability. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Subjective Tinnitus

Drugs mentioned

• Neramexane (neramexane)

Snippet

Sponsor: Merz Pharmaceuticals GmbH | Conditions: Subjective Tinnitus | Phase 3 | Status: COMPLETED